Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 123 results:
Συντάκτης Τίτλος [ Τύπος(Asc)] Έτος
Φίλτρα: Συντάκτης is Tsapas, Apostolos  [Clear All Filters]
Journal Article
Mantsiou, C., Karagiannis T., Kakotrichi P., Malandris K., Avgerinos I., Liakos A., et al. (2020).  Glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors as combination therapy for type 2 diabetes: A systematic review and meta-analysis.. Diabetes Obes Metab. 22(10), 1857-1868.
Tsapas, A., Karagiannis T., Avgerinos I., Liakos A., & Bekiari E. (2021).  GLP-1 receptor agonists for cardiovascular outcomes with and without metformin. A systematic review and meta-analysis of cardiovascular outcomes trials.. Diabetes Res Clin Pract. 177, 108921.
Karagiannis, T., Tsapas A., Athanasiadou E., Avgerinos I., Liakos A., Matthews D. R., et al. (2021).  GLP-1 receptor agonists and SGLT2 inhibitors for older people with type 2 diabetes: A systematic review and meta-analysis.. Diabetes Res Clin Pract. 174, 108737.
Anyfanti, P., Sampani E., & Tsapas A. (2021).  Fluid volume regulation in patients with heart failure.. Lancet Diabetes Endocrinol. 9(5), 257-258.
Liakopoulou, P., Liakos A., Vasilakou D., Athanasiadou E., Bekiari E., Kazakos K., et al. (2017).  Fixed ratio combinations of glucagon like peptide 1 receptor agonists with basal insulin: a systematic review and meta-analysis. Endocrine. 5625815134372239371731583439396341596(31134341111109129114943), 485 - 494.
Liakopoulou, P., Liakos A., Vasilakou D., Athanasiadou E., Bekiari E., Kazakos K., et al. (2017).  Fixed ratio combinations of glucagon like peptide 1 receptor agonists with basal insulin: a systematic review and meta-analysis.. Endocrine. 56(3), 485-494.
Klonizakis, P., Klaassen R., Sousos N., Liakos A., Tsapas A., & Vlachaki E. (2017).  Evaluation of the Greek TranQol: a novel questionnaire for measuring quality of life in transfusion-dependent thalassemia patients.. Ann Hematol. 96(11), 1937-1944.
Klonizakis, P., Klaassen R., Sousos N., Liakos A., Tsapas A., & Vlachaki E. (2017).  Evaluation of the Greek TranQol: a novel questionnaire for measuring quality of life in transfusion-dependent thalassemia patients. Annals of Hematology. 9635386959511886953716410511460363056271262012394215457(1111435131343Suppl 21151168618233445), 1937 - 1944.
Sarafidis, P. A., & Tsapas A. (2016).  Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.. N Engl J Med. 374(11), 1092.
Stamati, A., Karagiannis T., Tsapas A., & Christoforidis A. (2022).  Efficacy and safety of ultra-rapid insulin analogues in insulin pumps in patients with Type 1 Diabetes Mellitus: A systematic review and meta-analysis.. Diabetes Res Clin Pract. 193, 110144.
Avgerinos, I., Karagiannis T., Matthews D. R., Tsapas A., & Bekiari E. (2023).  Effects of sodium-glucose co-transporter-2 inhibitors by background cardiovascular medications: A systematic review and meta-analysis.. Diabetes Obes Metab. 25(10), 3020-3029.
Liakos, A., Athanasiadou E., Mainou M., Bekiari E., Haidich A. Bettina, Rizos E. C., et al. (2015).  Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia.. Ann Intern Med. 163(3), 241.
Alexandrou, M-E., Papagianni A., Tsapas A., Loutradis C., Boutou A., Piperidou A., et al. (2019).  Effects of mineralocorticoid receptor antagonists in proteinuric kidney disease: a systematic review and meta-analysis of randomized controlled trials.. J Hypertens. 37(12), 2307-2324.
Piperidou, A., Sarafidis P., Boutou A., Thomopoulos C., Loutradis C., Alexandrou M. Eleni, et al. (2019).  The effect of SGLT-2 inhibitors on albuminuria and proteinuria in diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials.. J Hypertens. 37(7), 1334-1343.
Piperidou, A., Sarafidis P., Boutou A., Thomopoulos C., Loutradis C., Alexandrou M. Eleni, et al. (2019).  The effect of SGLT-2 inhibitors on albuminuria and proteinuria in diabetes mellitus. Journal of Hypertension. 1.
Sarigianni, M., Maria S., Bekiari E., Eleni B., Tsapas A., Apostolos T., et al. (2010).  Effect of leptin and insulin resistance on properties of human monocytes in lean and obese healthy participants.. Angiology. 61(8), 768-74.
Sarigianni, M., Bekiari E., Tsapas A., Topouridou K., Kaloyianni M., Koliakos G., et al. (2011).  Effect of glucose and insulin on oxidized low-density lipoprotein phagocytosis by human monocytes: a pilot study.. Angiology. 62(2), 163-6.
Sarigianni, M., Bekiari E., Tsapas A., Konstantinidis D., Kaloyianni M., Koliakos G., et al. (2011).  Effect of epinephrine and insulin resistance on human monocytes obtained from lean and obese healthy participants: a pilot study.. Angiology. 62(1), 38-45.
Markozannes, G., Ntzani E. E., Tsapas A., Mantzoros C. S., Tsiara S., Xanthos T., et al. (2022).  Dose-related meta-analysis for Omega-3 fatty acids supplementation on major adverse cardiovascular events.. Clin Nutr. 41(4), 923-930.
Karagiannis, T., Paschos P., Paletas K., Matthews D. R., & Tsapas A. (2012).  Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis.. BMJ. 344, e1369.
Katsoula, A., Paschos P., Haidich A-B., Tsapas A., & Giouleme O. (2017).  Diagnostic Accuracy of Fecal Immunochemical Test in Patients at Increased Risk for Colorectal Cancer. JAMA Internal Medicine. 177(8), 1110.
Papanastasiou, C. A., Kampaktsis P. N., Bazmpani M-A., Zegkos T., Efthimiadis G., Tsapas A., et al. (2023).  Diagnostic Accuracy of CMR With Late Gadolinium Enhancement for Ischemic Cardiomyopathy: A Systematic Review and Meta-Analysis.. JACC Cardiovasc Imaging. 16(3), 399-401.
Kalymniou, M., Dimitriadou M., Slavakis A., Tsapas A., Galli-Tsinopoulou A., & Christoforidis A. (2019).  Decreased cortisol response to low-dose Synacthen test in pediatric patients with type 1 diabetes.. J Diabetes. 11(9), 773-774.
Papadopoulou, E., Theodorakopoulou M. P., Loutradis C., Tzanis G., Tzatzagou G., Kotsa K., et al. (2021).  Dapagliflozin Does Not Affect Short-Term Blood Pressure Variability in Patients With Type 2 Diabetes Mellitus.. Am J Hypertens. 34(4), 404-413.
Papadopoulou, E., Loutradis C., Tzatzagou G., Kotsa K., Zografou I., Minopoulou I., et al. (2020).  Dapagliflozin decreases ambulatory central blood pressure and pulse wave velocity in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial.. J Hypertens.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές